ABCB1 and breast carcinoma: In this study, we explored the potential of siRNA-based therapies in combination with the chemotherapeutic agent vinorelbine to combat drug resistance in breast cancer cells, particularly MCF-7/ADR cells with high ABCB1 expression levels.